Adicet Bio

ACETNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$85.611 M

$9.15 +2.41%

Close of 22 Sept 2026

Revenue

—

Not reported

Earnings

-$116.8M

Loss-making

Shares outstanding

9,361,490

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 499 →

#315RallybioRLYB$89.9M
#316Telomir PharmaceuticalsTELO$86.0M
#317Adicet BioACET$85.6M
#318iBioIBIO$85.5M
#319Gain TherapeuticsGANX$85.1M

What if Adicet Bio were worth as much as…

Open the what-if tool →

Gold $30.2T

$3,229,611

Per share 353,156× higher

Bitcoin $1.74T

$186,044.64

Per share 20,344× higher

Nvidia $5.52T

$589,197.55

Per share 64,428× higher

Or at a round number

$200.0M $500.0M $1.00B $2.00B

Where these numbers come from

Share counts and financials for Adicet Bio are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 23 Sept 2026. Read the methodology.